Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir-penciclovir Cream vs Abreva for Herpes Labialis
NCT06558838Phase 2Completed
- Sponsor
- University of Utah
- Start
- Aug 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of acyclovir and penciclovir in herpes labialis (2 arms), sponsored by University of Utah. Primary endpoint: Proportion of Subjects Who do Not Progress to Stage 3 (Vesicle) of a Herpes Labialis Outbreak Following UV Radiation Exposure up to 25 days. Started Aug 2024; status: completed.
02
Drugs
acyclovirpenciclovir
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT06558838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06558838.